Skip to main content
Skip to main content
ELV logo

Elevance Health Inc. (ELV)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Elevance Health Inc. (ELV) trades at $363.51 with AI Score 46/100 (Weak). Elevance Health Inc. is a health benefits company serving approximately 118 million people. Market cap: 80786012738, Sector: Healthcare.

Last analyzed: Feb 8, 2026
Elevance Health Inc. is a health benefits company serving approximately 118 million people. They offer a diverse portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions.
46/100 AI Score MCap 81B Vol 2M

Elevance Health Inc. (ELV) Healthcare & Pipeline Overview

CEOGail Koziara Boudreaux
Employees104200
HeadquartersIndianapolis, IN, US
IPO Year2001

Elevance Health delivers comprehensive health benefits and care solutions to approximately 118 million individuals, leveraging digital innovation and a broad portfolio of services to improve health outcomes and drive sustainable growth in the evolving healthcare landscape, supported by a 2.02% dividend yield.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Feb 8, 2026

Investment Thesis

Elevance Health presents a notable research candidate due to its strong market position, diversified service offerings, and commitment to innovation. With a P/E ratio of 13.28 and a dividend yield of 2.02%, the company offers a blend of value and income. Key value drivers include the continued expansion of its digital health platform, the growth of its specialty pharmacy services, and its ability to manage medical costs effectively. Upcoming catalysts include the further integration of its various business segments and the potential for strategic acquisitions. The company's focus on value-based care and its ability to adapt to the evolving healthcare landscape position it for long-term growth. Investors may want to evaluate Elevance Health for its potential to deliver sustainable earnings growth and attractive shareholder returns.

Based on FMP financials and quantitative analysis

Key Highlights

  • Elevance Health serves approximately 118 million people, demonstrating its significant market reach.
  • The company's P/E ratio of 13.28 suggests a reasonable valuation relative to its earnings.
  • A dividend yield of 2.02% provides an attractive income stream for investors.
  • Elevance Health's gross margin of 56.2% indicates efficient cost management and strong pricing power.
  • The company's beta of 0.50 suggests lower volatility compared to the overall market.

Competitors & Peers

Strengths

  • Large and diverse membership base.
  • Strong financial performance and profitability (2.8% Profit Margin).
  • Extensive network of providers.
  • Commitment to innovation and technology.

Weaknesses

  • Exposure to regulatory changes and healthcare reform.
  • Dependence on government programs.
  • Competition from other large health insurers.
  • Potential for medical cost inflation.

Catalysts

  • Continued expansion of digital health platform and services.
  • Growth in specialty pharmacy business.
  • Potential strategic acquisitions to expand market presence.
  • Implementation of value-based care initiatives to improve outcomes and reduce costs.
  • New partnerships with healthcare providers to enhance network coverage.

Risks

  • Changes in government regulations could negatively impact revenue and profitability.
  • Rising healthcare costs could erode margins.
  • Increased competition could lead to pricing pressure.
  • Economic downturn could reduce membership and premium revenue.
  • Cybersecurity breaches could compromise member data and disrupt operations.

Growth Opportunities

  • Expansion of Digital Health Platform: Elevance Health has a significant opportunity to expand its digital health platform, offering virtual care, remote monitoring, and personalized health coaching. The digital health market is projected to reach $660 billion by 2028, driven by increasing adoption of telehealth and mobile health apps. By leveraging technology, Elevance Health can improve access to care, enhance patient engagement, and reduce costs. This expansion will allow Elevance to reach more members and provide more personalized care.
  • Growth of Specialty Pharmacy Services: Elevance Health can further grow its specialty pharmacy services, which provide medications and support for patients with complex conditions. The specialty pharmacy market is expected to reach $400 billion by 2026, driven by the increasing prevalence of chronic diseases and the development of new specialty drugs. By expanding its specialty pharmacy capabilities, Elevance Health can improve medication adherence, reduce healthcare costs, and generate additional revenue.
  • Strategic Acquisitions and Partnerships: Elevance Health can pursue strategic acquisitions and partnerships to expand its service offerings and geographic reach. The healthcare industry is undergoing rapid consolidation, and companies that can effectively integrate acquisitions will be well-positioned for growth. By acquiring companies with complementary capabilities, Elevance Health can strengthen its competitive position and create synergies. These acquisitions can help Elevance expand into new markets and offer a wider range of services to its members.
  • Value-Based Care Initiatives: Elevance Health can continue to expand its value-based care initiatives, which align incentives to improve quality and reduce costs. Value-based care models are gaining traction as payers and providers seek to improve outcomes and lower healthcare spending. By partnering with providers to implement value-based care programs, Elevance Health can improve the quality of care for its members and reduce overall healthcare costs. This approach will also help Elevance attract and retain members.
  • Government Programs and Medicaid Expansion: Elevance Health can capitalize on the expansion of government-sponsored healthcare programs, such as Medicaid. As more states expand Medicaid eligibility, Elevance Health has the opportunity to enroll new members and grow its market share. By participating in government programs, Elevance Health can diversify its revenue streams and serve a broader population. The company's experience in managing government programs positions it well to succeed in this market.

Opportunities

  • Expansion of digital health services.
  • Growth of specialty pharmacy services.
  • Strategic acquisitions and partnerships.
  • Expansion of value-based care initiatives.

Threats

  • Increased competition from new entrants.
  • Rising healthcare costs.
  • Changes in government regulations.
  • Economic downturn.

Competitive Advantages

  • Large membership base provides economies of scale and bargaining power.
  • Extensive network of providers offers broad access to care.
  • Strong brand recognition and reputation for quality.
  • Proprietary technology and data analytics capabilities.

About ELV

Elevance Health Inc., formerly known as Anthem, Inc., was founded in 1944 and is headquartered in Indianapolis, Indiana. The company rebranded in June 2022 to reflect its broader mission beyond traditional health insurance. Elevance Health operates as a health benefits company, dedicated to supporting consumers, families, and communities throughout their healthcare journey. It connects individuals with the necessary care, support, and resources to facilitate healthier lives. Elevance Health serves approximately 118 million people through a comprehensive portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. These offerings span the entire spectrum of healthcare needs, from preventative care and chronic disease management to acute care and specialized treatments. The company's commitment to innovation and technology enables it to deliver personalized and efficient healthcare experiences. Elevance Health's market position is strengthened by its extensive network of providers and its focus on value-based care models. This approach aligns incentives to improve quality and reduce costs, benefiting both members and the healthcare system as a whole.

What They Do

  • Provides medical benefits plans to individuals, families, and employer groups.
  • Offers digital health solutions, including telehealth and mobile apps.
  • Manages pharmacy benefits, including prescription drug coverage and specialty pharmacy services.
  • Provides behavioral health services, including mental health and substance abuse treatment.
  • Offers clinical care management programs for chronic conditions.
  • Connects individuals with care, support, and resources to lead healthier lives.
  • Focuses on value-based care models to improve quality and reduce costs.

Business Model

  • Generates revenue from premiums paid by members for health insurance coverage.
  • Earns fees from managing pharmacy benefits for employers and other organizations.
  • Receives payments for providing clinical care management services.
  • Profits from managing risk and controlling healthcare costs.

Industry Context

Elevance Health operates in the medical healthcare plans industry, which is characterized by increasing consolidation and a growing emphasis on value-based care. The industry is influenced by factors such as government regulations, technological advancements, and changing consumer preferences. The competitive landscape includes established players like CI and CVS, as well as emerging disruptors focused on digital health solutions. Elevance Health's size and scale provide it with a competitive advantage, but it must continue to innovate and adapt to remain successful in this dynamic environment. The industry is expected to grow as the population ages and demand for healthcare services increases.

Key Customers

  • Individuals and families seeking health insurance coverage.
  • Employers offering health benefits to their employees.
  • Government agencies sponsoring healthcare programs.
  • Healthcare providers participating in Elevance Health's networks.
AI Confidence: 73% Updated: Feb 8, 2026

Financials

Chart & Info

Elevance Health Inc. (ELV) stock price: $363.51 (+9.26, +2.61%)

Latest News

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ELV.

Price Targets

Wall Street price target analysis for ELV.

MoonshotScore

46/100

What does this score mean?

The MoonshotScore rates ELV's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

What Investors Ask About Elevance Health Inc. (ELV) — Healthcare

What does Elevance Health Inc. do?

Elevance Health Inc. operates as a health benefits company, providing a range of medical, digital, pharmacy, behavioral, clinical, and care solutions to approximately 118 million people. The company connects consumers, families, and communities with the care, support, and resources they need to lead healthier lives. Elevance Health generates revenue primarily through premiums paid by members for health insurance coverage and fees from managing pharmacy benefits and clinical care management services. The company focuses on managing risk, controlling healthcare costs, and delivering value to its members and shareholders.

Is ELV stock worth researching?

Elevance Health (ELV) presents a mixed investment profile. The company's strong market position and diversified service offerings are positives, as is its 2.02% dividend yield. However, potential investors may want to evaluate the risks associated with regulatory changes and rising healthcare costs. With a P/E ratio of 13.28, the stock appears reasonably valued, but future growth depends on the company's ability to innovate and adapt to the evolving healthcare landscape. A balanced analysis suggests that ELV could be worth researching for investors seeking a combination of value and income, but careful consideration of the risks is essential.

What are the main risks for ELV?

Elevance Health faces several key risks. Changes in government regulations, such as the Affordable Care Act, could significantly impact the company's revenue and profitability. Rising healthcare costs, driven by factors such as new technologies and an aging population, could erode margins. Increased competition from other large health insurers and new entrants could lead to pricing pressure. An economic downturn could reduce membership and premium revenue. Additionally, cybersecurity breaches pose a threat to member data and operational stability. These risks require careful monitoring and proactive mitigation strategies.

What are the key factors to evaluate for ELV?

Elevance Health Inc. (ELV) currently holds an AI score of 46/100, indicating low score. Key strength: Large and diverse membership base. Primary risk to monitor: Changes in government regulations could negatively impact revenue and profitability. This is not financial advice.

How frequently does ELV data refresh on this page?

ELV prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven ELV's recent stock price performance?

Recent price movement in Elevance Health Inc. (ELV) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Large and diverse membership base. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider ELV overvalued or undervalued right now?

Determining whether Elevance Health Inc. (ELV) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying ELV?

Before investing in Elevance Health Inc. (ELV), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • Information is based on available data and may be subject to change.
  • Financial metrics are as of the latest available reporting period.
Data Sources

Popular Stocks